Dexamethasone Sodium Phosphate
NDC Package 16590-068-05
Package Information
Dexamethasone Sodium Phosphate is iNDICATIONS AND USAGEFor the treatment of the following conditions:Ophthalmic Steroid responsive inflammatory conditions of the palpebral and bulbar conjunctiva, cornea, and anterior segment of the globe, such as allergic conjunctivitis, acne rosacea, superficial punctate keratitis, herpes zoster keratitis, iritis, cyclitis, selected infective conjunctivitis when the inherent hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation; corneal injury from chemical or thermal burns, or penetration of foreign bodies.Otic Steroid responsive inflammatory conditions of the external auditory meatus, such as allergic otitis externa, selected purulent and nonpurulent infective otitis externa when the hazard of steroid use is accepted to obtain an advisable diminution in edema and inflammation. Marketed by Stat Rx Usa, this product is identified by NDC 16590-068 and is authorized under FDA application ANDA040069.
Identification & Billing
- RxCUI: 226343 - dexAMETHasone sodium phosphate 0.1 % Ophthalmic Solution
- RxCUI: 226343 - dexamethasone phosphate 1 MG/ML Ophthalmic Solution
- RxCUI: 226343 - dexamethasone sodium phosphate 0.1 % Ophthalmic Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 16590 - Stat Rx Usa
- 16590-068 - Dexamethasone Sodium Phosphate
- 16590-068-05 - 1 BOTTLE, DROPPER in 1 CARTON / 5 mL in 1 BOTTLE, DROPPER
- 16590-068 - Dexamethasone Sodium Phosphate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 16590-068-05 identifies a specific commercial package of 1 bottle, dropper in 1 carton / 5 ml in 1 bottle, dropper of Dexamethasone Sodium Phosphate, labeled by Stat Rx Usa. This product is billed per "ML" milliliter and contains an estimated amount of 5 billable units per package. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Stat Rx Usa on July 26, 1996. The current certification is valid through December 31, 2017.
How is this Stat Rx Usa product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 16590006805. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 5 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.